tiprankstipranks
Trending News
More News >
Savara (SVRA)
NASDAQ:SVRA

Compare Savara (SVRA) vs. Competitors

Compare
1,235 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Savara
$5.82
$1.18B
-10.88
100.00%
6 Buy
0 Hold
0 Sell
Strong Buy
Rigel
$37.48
$680.31M
6.08
116.02%
3 Buy
1 Hold
0 Sell
Strong Buy
AnaptysBio
$45.68
$1.26B
-16.20
203.93%
9 Buy
1 Hold
0 Sell
Strong Buy
Olema Pharmaceuticals
$27.14
$2.13B
-14.98
414.02%
11 Buy
0 Hold
0 Sell
Strong Buy
Nanobiotix
$20.07
$1.04B
609.12%
0 Buy
1 Hold
0 Sell
Hold
Bicara Therapeutics Inc.
$16.75
$917.60M
-7.51
40.99%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SVRA
Savara
5.82
3.02
107.86%
RIGL
Rigel
37.48
15.67
71.85%
ANAB
AnaptysBio
45.68
28.80
170.62%
OLMA
Olema Pharmaceuticals
27.14
21.64
393.45%
NBTX
Nanobiotix
20.99
17.74
545.85%
BCAX
Bicara Therapeutics Inc.
16.75
4.67
38.66%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts